Sanofi GCVRZ 深 沪
等待开盘 12-16 09:30:00 美东时间
0.8711
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.8711
- 总市值 1113.52亿
- 52周最高 0.882
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.43
- 委 比 0.00%
- 总股本 1278.30亿
- 历史最高 0.882
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.153
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration
Sanofi expands its partnership with Dren Bio in a deal featuring $100 million upfront and up to $1.7 billion tied to a next-generation autoimmune B-cell therapy.
今天 02:10
Canopy Growth To Acquire MTL Cannabis
Canopy Growth Corp. (NASDAQ: CGC) to acquire MTL Cannabis Corp. (OTCQX: MTLNF) for approx. 125 million CAD in cash and stock.
今天 00:28
Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback
Cencora agrees to buy a majority stake in OneOncology for about $5 billion, pauses buybacks, and reiterates fiscal 2026 sales and EPS guidance.
12-15 22:09
Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks
Sanofi said its Phase 3 PERSEUS trial of tolebrutinib missed the primary endpoint in PPMS, ending plans for regulatory filing.
12-15 20:52
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immu...
12-12 23:47
FDA plans to put “black box” warning on Covid vaccines: report
The US Food and Drug Administration (FDA) plans to add a “black box” warning to COVID-19 vaccines, CNN reported, citing two people familiar with the decision. A boxed warning—the FDA’s most serious al...
12-12 19:45
CDC study finds COVID shot significantly reduced ER visits for children
A fresh study authored by CDC scientists is throwing water on the argument that children do not need the COVID-19 vaccine. Investigators examined electronic health records in nine states of emergency ...
12-12 06:37
FDA expands COVID-19 shot safety probe to include adults - report
The US FDA is now investigating whether COVID-19 vaccines are tied to deaths in adults. The agency is "doing a thorough investigation, across multiple age groups, of deaths potentially related to Covi...
12-10 06:34
Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks
U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of products from major drugmakers.
12-10 00:30
RSV shots for infants reportedly under FDA scrutiny
The Food and Drug Administration (FDA) has indicated plans to conduct a fresh review of currently marketed RSV treatments for infants following safety concerns raised by vaccine skeptics, Reuters repo...
12-09 22:12
